Utah Medical Products, Inc.
NASDAQ Global SelectTotal Valuation
Utah Medical Products, Inc. carries a market capitalization of 222.25M, placing it among publicly traded companies globally. Its enterprise value stands at 111.55M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 222.25M |
| Enterprise Value | 111.55M |
Share Statistics
Utah Medical Products, Inc. currently has 3.18M shares outstanding.
| Shares Outstanding | 3.18M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Utah Medical Products, Inc. trades at a trailing price-to-earnings ratio of 18.32. The price-to-sales ratio is 5.30, and the price-to-book ratio stands at 1.53.
| PE Ratio | 18.32 |
| PS Ratio | 5.30 |
| PB Ratio | 1.53 |
| P/TBV Ratio | 1.87 |
| P/FCF Ratio | 14.77 |
| P/OCF Ratio | 14.90 |
Enterprise Valuation
On an enterprise value basis, Utah Medical Products, Inc. trades at an EV/EBITDA multiple of 7.84 and an EV/FCF ratio of 8.28. The EV/Sales ratio of 2.97 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 9.91 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.97 |
| EV / EBITDA | 7.84 |
| EV / EBIT | 9.91 |
| EV / FCF | 8.28 |
Financial Position
Utah Medical Products, Inc. maintains a current ratio of 28.64, meaning it holds 28.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 28.64 |
| Quick Ratio | 25.97 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 0.01 |
| Interest Coverage | N/A |
Financial Efficiency
Utah Medical Products, Inc. posts a return on equity of 8.39 and a return on invested capital of 7.64.
| Return on Equity (ROE) | 8.39 |
| Return on Assets (ROA) | 8.79 |
| Return on Invested Capital (ROIC) | 7.64 |
| Return on Capital Employed (ROCE) | 8.38 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.82 |
Taxes
Over the trailing twelve months, Utah Medical Products, Inc. has paid 2.58M in income taxes, reflecting an effective tax rate of 19.24.
| Income Tax | 2.58M |
| Effective Tax Rate | 19.24 |
Stock Price Statistics
Utah Medical Products, Inc.'s stock has gained approximately 25.72046% over the past 52 weeks. The 50-day moving average sits at 67.29, while the 200-day moving average is 62.88.
| Beta (5Y) | N/A |
| 52-Week Price Change | 25.72046% |
| 50-Day Moving Average | 67.29 |
| 200-Day Moving Average | 62.88 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Utah Medical Products, Inc. generated 37.53M in revenue and converted that into 10.85M in net income, yielding earnings per share of 3.38. EBITDA reached 14.23M, while operating income came in at 11.25M.
| Revenue | 37.53M |
| Gross Profit | 21.75M |
| Operating Income | 11.25M |
| Pretax Income | 13.43M |
| Net Income | 10.85M |
| EBITDA | 14.23M |
| EBIT | 11.25M |
| Earnings Per Share (EPS) | 3.38 |
Balance Sheet
Utah Medical Products, Inc. holds 87.41M in cash and equivalents against 210,000.00 in total debt, resulting in a net debt position of -87.41M. Total book value stands at 130.29M, with working capital of 96.87M providing operational flexibility.
| Cash & Cash Equivalents | 87.41M |
| Total Debt | 210,000.00 |
| Net Debt | -87.41M |
| Equity (Book Value) | 130.29M |
| Book Value Per Share | 40.64 |
| Working Capital | 96.87M |
Cash Flow
Utah Medical Products, Inc. produced 13.34M in operating cash flow over the past twelve months. After subtracting -130,000.00 in capital expenditures, free cash flow totaled 13.21M - equivalent to 4.12 per share.
| Operating Cash Flow | 13.34M |
| Capital Expenditures | -130,000.00 |
| Free Cash Flow | 13.21M |
| FCF Per Share | 4.12 |
Margins
Utah Medical Products, Inc. operates with a gross margin of 57.94, reflecting its pricing power and cost economics. The operating margin of 29.99 and net profit margin of 28.91 provide insight into operational efficiency.
| Gross Margin | 57.94 |
| Operating Margin | 29.99 |
| Pretax Margin | 35.79 |
| Profit Margin | 28.91 |
| EBITDA Margin | 37.91 |
Dividends & Yields
The company's payout ratio of 36.45 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 1.23 |
| Dividend Yield | N/A |
| Payout Ratio | 36.45 |
| Shareholder Yield | 4.64 |
| FCF Yield | 6.77 |
Stock Splits
Utah Medical Products, Inc.'s most recent stock split took place on March 22, 1993 with a 2:3 split ratio.
| Last Split Date | 3/22/1993 |
| Split Ratio | 2:3 |
Scores
Utah Medical Products, Inc. posts an Altman Z-Score of 33.13, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 33.13 |